Form 4: Zoetis Executive Vice President Keith Sarbaugh Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Keith Sarbaugh reports transactions involving Zoetis Inc. stock, including the vesting of restricted stock units and the disposition of shares to cover tax obligations.
Summary
- Keith Sarbaugh, an Executive Vice President at Zoetis Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 31, 2025, Sarbaugh acquired 1,506 shares of common stock upon the vesting and settlement of restricted stock units (RSUs).
- Also on March 31, 2025, Sarbaugh disposed of 516 shares of common stock at a price of $164.65 to satisfy tax obligations related to the vesting of the RSUs.
- Following these transactions, Sarbaugh directly owns 2,039 shares of Zoetis common stock.
- He also holds derivative securities, including phantom stock units and restricted stock units, representing rights to acquire additional shares of Zoetis common stock.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about an executive's stock ownership.
Positives
- The vesting of restricted stock units indicates that Sarbaugh has met certain performance or service requirements, aligning his interests with those of the company and its shareholders.
Negatives
- The disposition of shares to cover tax obligations, while a common practice, slightly reduces Sarbaugh's direct ownership stake in Zoetis.
Future Outlook
The document does not contain specific forward-looking statements, but it details the vesting schedule of existing restricted stock units, indicating future stock acquisitions by the reporting person.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the stock ownership of company insiders. These filings are closely watched by investors to gauge management's alignment with shareholder interests.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive incentives with long-term company performance.
- The vesting schedules and terms of Sarbaugh's RSUs are typical for executive compensation plans in publicly traded companies like Zoetis.
- Similar to other executives in comparable companies such as Elanco or Merck Animal Health, Sarbaugh's stock transactions are subject to SEC regulations and reporting requirements.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock ownership.
- The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/28/2025 | Date of phantom stock unit acquisition. |
| 03/31/2025 | Date of common stock acquisition and disposition due to RSU vesting and tax obligations. |
| 04/01/2025 | Date of Form 4 filing. |
Keywords
Zoetis, Sarbaugh, Stock, Restricted Stock Units, RSU, Form 4, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.